Ainhoa M.
- Country
- Spain
- Department
- Oncology
Research Overview
- Phase 1 Evaluation of ATV-1601 in Patients with Advanced Solid Tumors and Breast Cancer Harboring AKT1 E17K Mutations
- Phase 1 Study of STRO-002 and Bevacizumab in Advanced Epithelial Ovarian Cancer, Including Fallopian Tube and Primary Peritoneal Cancers
- A Phase II Study of MEN2501 in Patients with Platinum-Resistant Ovarian Cancer
Data & Insights
Has run more than one trial at 17 of 72 partner sites.
Specializations
Gynecologic Oncology
The investigator specializes in treating complex cases of ovarian cancer, with particular focus on both standard and innovative therapeutic approaches. Their expertise extends to managing platinum-resistant cases and oligometastatic disease progression.
- Epithelial ovarian cancer
- Fallopian tube cancer
- Primary peritoneal cancer
Their work encompasses comprehensive treatment strategies for gynecologic malignancies, including surgical interventions and targeted therapies.
Immunotherapy Research
The investigator focuses on advancing immunotherapeutic approaches in gynecologic cancers, including novel combinations with established treatments. Their work involves genetically modified T-cell therapies and immune checkpoint inhibitors.
- T-cell based treatments
- Combination immunotherapy
- Targeted molecular therapies
A particular interest lies in investigating immune responses in MAGE-A4 positive and HLA-A2 positive cancer patients.
Advanced Cancer Treatment
The investigator explores treatment options for multiple solid tumors, with expertise in managing advanced-stage cancers. Their therapeutic scope includes innovative drug development and treatment strategies for various cancer types.
- Endometrial cancer
- Non-small cell lung cancer
- Triple-negative breast cancer
- Gastrointestinal cancers
Their approach incorporates both targeted therapies and novel therapeutic agents for treatment-resistant cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.